KIRA-7
KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect[1].
Product Specifications
CAS Number
[1937235-76-1]
UNSPSC
12352005
Target
IRE1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kira-7.html
Concentration
10mM
Purity
99.09
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(F)=C1)NC2=C3C=CC=CC3=C(C4=C5C(N)=NC=CN5C(C6(C)CC6)=N4)C=C2
Molecular Formula
C27H23FN6O
Molecular Weight
466.51
References & Citations
[1]Thamsen M, et al. Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung. PLoS One. 2019 Jan 9;14 (1) :e0209824.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TMM70, CT (TMEM70, Transmembrane protein 70, mitochondrial) (FITC) discontinued
Lentiviral mouse Dpcd shRNA (UAS) - Lentiviral mouse Dpcd shRNA (UAS, GFP) (100)
Recombinant Staphylococcus aureus Probable DNA-directed RNA polymerase subunit delta (rpoE)
Recombinant Staphylococcus aureus Probable DNA-directed RNA polymerase subunit delta (rpoE)